| Literature DB >> 25191308 |
Marta S Alves1, Anabela Pereira1, Susana M Araújo1, Bruno B Castro1, António C M Correia1, Isabel Henriques1.
Abstract
The aim of this study was to examine antibiotic resistance (AR) dissemination in coastal water, considering the contribution of different sources of fecal contamination. Samples were collected in Berlenga, an uninhabited island classified as Natural Reserve and visited by tourists for aquatic recreational activities. To achieve our aim, AR in Escherichia coli isolates from coastal water was compared to AR in isolates from two sources of fecal contamination: human-derived sewage and seagull feces. Isolation of E. coli was done on Chromocult agar. Based on genetic typing 414 strains were established. Distribution of E. coli phylogenetic groups was similar among isolates of all sources. Resistances to streptomycin, tetracycline, cephalothin, and amoxicillin were the most frequent. Higher rates of AR were found among seawater and feces isolates, except for last-line antibiotics used in human medicine. Multi-resistance rates in isolates from sewage and seagull feces (29 and 32%) were lower than in isolates from seawater (39%). Seawater AR profiles were similar to those from seagull feces and differed significantly from sewage AR profiles. Nucleotide sequences matching resistance genes bla TEM, sul1, sul2, tet(A), and tet(B), were present in isolates of all sources. Genes conferring resistance to 3rd generation cephalosporins were detected in seawater (bla CTX-M-1 and bla SHV-12) and seagull feces (bla CMY-2). Plasmid-mediated determinants of resistance to quinolones were found: qnrS1 in all sources and qnrB19 in seawater and seagull feces. Our results show that seawater is a relevant reservoir of AR and that seagulls are an efficient vehicle to spread human-associated bacteria and resistance genes. The E. coli resistome recaptured from Berlenga coastal water was mainly modulated by seagulls-derived fecal pollution. The repertoire of resistance genes covers antibiotics critically important for humans, a potential risk for human health.Entities:
Keywords: Escherichia coli; Microbial source tracking; antibiotic resistance; fecal pollution; water quality
Year: 2014 PMID: 25191308 PMCID: PMC4138442 DOI: 10.3389/fmicb.2014.00426
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
PCR primers and conditions for AR genes amplification.
| OXA_F:TTGGTGGCATCGATTATCGG OXA_R: GAGCACTTCTTTTGTGATGGC | 744 | E | 55 | Poirel et al., | ||
| TEM_F: AAAGATGCTGAAGATCA TEM_R: TTTGGTATGGCTTCATTC | 425 | B | 44 | Speldooren et al., | ||
| SHV_F: GCGAAAGCCAGCTGTCGGGC SHV_R: GATTGGCGGCGCTGTTATCGC | 304 | B | 62 | Henriques et al., | ||
| CTX_F: SCVATGTGCAGYACCAGTAA CTX_R: GCTGCCGGTYTTATCVCC | 652 | A | 55 | Lu et al., | ||
| IMP_F: GAATAGAGTGGCTTAATTGTC IMP_R: GGTTTAAYAAAACAACCACC | 232 | B | 55 | Henriques et al., | ||
| VIM_F: GATGGTGTTTGGTCGCATATCG VIM_R: GCCACGTTCCCCGCAGACG | 475 | B | 58 | Henriques et al., | ||
| KPC_F: CATTCAAGGGCTTTCTTGCTGC KPC_R: ACGACGGCATAGTCATTT | 538 | B | 55 | Dallenne et al., | ||
| GES_F: AGTCGGCTAGACCGGAAAG GES_R: TTTGTCCGTGCTCAGGAT | 399 | D | 57 | Dallenne et al., | ||
| tetA_F: GCTACATCCTGCCTTC tetA_R: GCATAGATCGGAAGAG | 211 | C | 53 | Nawaz et al., | ||
| tetB_F: TCATTGCCGACCTCAG tetB_R: CCAACCATCACCATCC | 391 | C | 53 | Nawaz et al., | ||
| qnrA_F: TTCTCACGCCAGGATTTG qnrA_R: CCATCCAGATCGGCAAA | 521 | C | 53 | Guillard et al., | ||
| qnrB_F: GGMATHGAAATTCGCCACTG qnrB_R: TTYGCBGYYCGCCAGTCG | 261 | C | 53 | Cattoir et al., | ||
| qnrS_F: GCAAGTTCATTGAACAGGGT qnrS_R: TCTAAACCGTCGAGTTCGGCG | 428 | C | 54 | Cattoir et al., | ||
| sul1_F: CTGAACGATATCCAAGGATTYCC sul1_R: AAAAATCCCACGGRTC | 239 | C | 50 | Heuer and Smalla, | ||
| sul2_F: GCGCTCAAGGCAGATGGCAT sul2_R: GCGTTTGATACCGGCACCCG | 293 | C | 60 | Henriques et al., |
A, B, C, D, and E represent different PCR programs (see Table .
Figure 1Distribution of the .
Figure 2Total resistance frequencies to 16 antibiotics of . AMP, ampicillin; AML, amoxicillin; AMC, amoxicillin/clavulanic acid; PRL, piperacillin; TZP, piperacillin/tazobactam; KF, cephalothin; CAZ, ceftazidime; CTX, cefotaxime; IMP, imipenem; CN, gentamicin; S, streptomycin; NA, nalidixic acid; CIP, ciprofloxacin; TE, tetracycline; C, chloramphenicol; SXT, sulfamethoxazole/trimethoprim.
Figure 3PCA biplot of . Arrows represent antibiotics: AMP, ampicillin; AML, amoxicillin; AMC, amoxicillin/clavulanic acid; PRL, piperacillin; TZP, piperacillin/tazobactam; KF, cephalothin; CAZ, ceftazidime; CTX, cefotaxime; IMP, imipenem; CN, gentamicin; S, streptomycin; NA, nalidixic acid; CIP, ciprofloxacin; TE, tetracycline; C, chloramphenicol; SXT, sulfamethoxazole/trimethoprim. TZP, CAZ, CTX, IMP have little influence in the ordination, thus respective arrows are not perceptible. Scores are depicted according to the number of antibiotic classes that isolates are resistant to (0–6; left panel) or source of origin (right panel).
AR phenotypes detected in seawater and in at least one of the putative pollution sources (i.e., seagull feces and sewage).
| S | 31 | 39 | 20 | 90 (21.7) |
| S, TE | 14 | 13 | 3 | 30 (7.2) |
| KF, S | 22 | 5 | 0 | 27 (6.5) |
| AML, KF, S | 6 | 4 | 1 | 11 (2.7) |
| IPM, S | 4 | 4 | 0 | 8 (1.9) |
| S, NA | 4 | 1 | 1 | 6 (1.4) |
| AMP, AML, PRL, KF, S, TE | 2 | 3 | 1 | 6 (1.4) |
| AMP, AML, PRL, KF, S, TE, STX | 2 | 4 | 0 | 6 (1.4) |
| AML, S | 1 | 3 | 1 | 5 (1.2) |
| AMP, S | 1 | 0 | 3 | 4 (1.0) |
| S, NA, TE | 2 | 1 | 1 | 4 (1.0) |
| AMP, AML, PRL, S, TE | 2 | 1 | 1 | 4 (1.0) |
| AMC, S | 1 | 2 | 0 | 3 (0.7) |
| S, TE, STX | 2 | 1 | 0 | 3 (0.7) |
| AML, KF, S, TE | 2 | 1 | 0 | 3 (0.7) |
| AMP, AML, KF, S | 1 | 2 | 0 | 3 (0.7) |
| AMP, AML, PRL, S | 1 | 2 | 0 | 3 (0.7) |
| AMP, AML, PRL, S, TE, STX | 2 | 1 | 0 | 3 (0.7) |
| AMP, AML, AMC, PRL, KF, S, TE, C, STX | 1 | 1 | 1 | 3 (0.7) |
| AMP, AML, PRL, KF, S, NA, CIP, TE, C, STX | 2 | 1 | 0 | 3 (0.7) |
| AMP, AML, AMC, KF, S | 0 | 2 | 0 | 2 (0.5) |
| KF, S, TE | 1 | 1 | 0 | 2 (0.5) |
| AMP, AML, PRL, KF, S, TE, C, STX | 1 | 1 | 0 | 2 (0.5) |
| AMP, AML, AMC, PRL, IPM, S, TE, C, STX | 1 | 0 | 1 | 2 (0.5) |
The number of isolates from each sampling source displaying each phenotype is presented.
AMP, ampicillin; AML, amoxicillin; AMC, amoxicillin/clavulanic acid; PRL, piperacillin; KF, cephalothin; IPM, imipenem; S, streptomycin; NA, nalidixic acid; CIP, ciprofloxacin; TE, tetracycline; C, chloramphenicol; STX, thrimethoprim/sulfamethoxazole.
Prevalence of resistance genes detected in the .
| 3rd generation cephalosporins and/or penicillins | 68 | 47 (69%) | 82 | 31 (38%) | 33 | 8 (24%) | |
| 1 (2%) | 0 | 0 | |||||
| 6 | 1 (17%) | 8 | 0 | 8 | 0 | ||
| 0 | 1 (13%) | 0 | |||||
| Quinolones | 39 | 1 (3%) | 30 | 2 (7%) | 17 | 0 | |
| 2 (5%) | 5 (17%) | 1 (6%) | |||||
| Tetracycline | 70 | 48 (69%) | 63 | 44 (70%) | 16 | 5 (31%) | |
| 22 (31%) | 15 (24%) | 6 (38%) | |||||
| Sulfonamide + trimethoprim | 28 | 8 (29%) | 32 | 8 (25%) | 7 | 2 (29%) | |
| 18 (64%) | 19 (60%) | 3 (43%) | |||||
bla.
bla.
AR genotypes detected in seawater and in at least one of the putative pollution sources (i.e., seagull feces and sewage).
| 21 | 20 | 3 | 44 (11.3) | |
| 13 | 6 | 2 | 21 (5.4) | |
| 7 | 8 | 2 | 17 (4.4) | |
| 7 | 3 | 2 | 12 (3.1) | |
| 4 | 5 | 0 | 9 (2.3) | |
| 4 | 5 | 0 | 9 (2.3) | |
| 3 | 4 | 1 | 8 (2.1) | |
| 4 | 1 | 0 | 5 (1.3) | |
| 1 | 3 | 0 | 4 (1.0) | |
| 2 | 0 | 2 | 4 (1.0) | |
| 1 | 2 | 0 | 3 (0.8) | |
| 1 | 1 | 1 | 3 (0.8) | |
| 1 | 2 | 0 | 3 (0.8) | |
| 1 | 1 | 0 | 2 (0.5) |
The number of isolates from each sampling source displaying each phenotype is presented.